Literature DB >> 10777832

Interrupted aortic arch: an epidemiologic study.

C A Loffredo1, C Ferencz, P D Wilson, I W Lurie.   

Abstract

BACKGROUND: Interruption of the aortic arch (IAA) is a rare but severe anomaly associated with major intracardiac defects and with multisystem noncardiac malformations, recently linked to chromosome deletion of 22q11.2.
METHODS: The Baltimore-Washington Infant Study (1981-1989), a population-based epidemiologic study of cardiovascular malformations, evaluated 53 infants with IAA in comparison with 3,572 controls. Risk factors for the anatomic subtypes were evaluated in 14 cases of IAA type A and 32 cases of IAA type B, but no molecular genetic tests were available. The distribution of associated cardiac defects was similar for both types.
RESULTS: DiGeorge syndrome (DGS) occurred more frequently in IAA type B. Case-control comparisons demonstrated that infants in both groups were growth retarded at birth. A family history of noncardiac defects occurred only in IAA type B cases and included relatives with cleft lip and/or cleft palate. Candidate risk factors were associated only in type B cases and differed for those with (n = 10) and for those without (n = 19) DGS: a family history of noncardiac defects (odds ratio [OR] = 7.2, 95% confidence interval [CI] = 1.5-39.2) and maternal use of aspirin during the critical period (OR = 4.8, 95% CI = 1.3-25.4) occurred with DGS, while previous stillbirth (OR = 9.4, 95% CI = 1.3-53.1), bleeding during pregnancy (OR = 3.7, 95% CI = 1.4-11.4), and maternal exposure to arts/crafts paints (OR = 4.8, 95% CI = 1.3-17.4) were associated in those without DGS.
CONCLUSIONS: These findings confirm the heterogeneity of IAA and of the type B subtype. Risk factors specific for cases with DGS may open a window to further investigations of the etiology of IAA and of the associated molecular genetic abnormalities. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10777832     DOI: 10.1002/(SICI)1096-9926(200005)61:5<368::AID-TERA8>3.0.CO;2-N

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  9 in total

1.  Case-control analysis of maternal prenatal analgesic use and cardiovascular malformations: Baltimore-Washington Infant Study.

Authors:  Courtney A Marsh; Janet D Cragan; C J Alverson; Adolfo Correa
Journal:  Am J Obstet Gynecol       Date:  2014-03-27       Impact factor: 8.661

2.  A cluster of hypoplastic left heart malformation in Baltimore, Maryland.

Authors:  K S Kuehl; C A Loffredo
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

Review 3.  Multislice CT angiography of interrupted aortic arch.

Authors:  Dong Hyun Yang; Hyun Woo Goo; Dong-Man Seo; Tae-Jin Yun; Jeong-Jun Park; In-Sook Park; Jae Kon Ko; Young Hwee Kim
Journal:  Pediatr Radiol       Date:  2007-10-27

Review 4.  Genetic basis of congenital cardiovascular malformations.

Authors:  Seema R Lalani; John W Belmont
Journal:  Eur J Med Genet       Date:  2014-04-30       Impact factor: 2.708

5.  Altered 4-D magnetic resonance imaging flow characteristics in complex congenital aortic arch repair.

Authors:  Lajja P Desai; Haben Berhane; Nazia Husain; Joshua D Robinson; Cynthia K Rigsby; Michael Markl
Journal:  Pediatr Radiol       Date:  2019-08-31

Review 6.  DiGeorge syndrome/chromosome 22q11.2 deletion syndrome.

Authors:  K E Sullivan
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

Review 7.  Nongenetic risk factors and congenital heart defects.

Authors:  Sonali S Patel; Trudy L Burns
Journal:  Pediatr Cardiol       Date:  2013-08-21       Impact factor: 1.655

8.  Clinical manifestations of Deletion 22q11.2 syndrome (DiGeorge/Velo-Cardio-Facial syndrome).

Authors:  Mc Digilio; B Marino; R Capolino; B Dallapiccola
Journal:  Images Paediatr Cardiol       Date:  2005-04

9.  Diagnostic Value of Prospective Electrocardiogram-triggered Dual-source Computed Tomography Angiography for Infants and Children with Interrupted Aortic Arch.

Authors:  Hai-Ou Li; Xi-Ming Wang; Pei Nie; Xiao-Peng Ji; Zhao-Ping Cheng; Jiu-Hong Chen; Zhuo-Dong Xu
Journal:  Chin Med J (Engl)       Date:  2015-05-05       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.